Click a link below to view the mailing archive as if it had been sent to you.
| 2015-07-31 12:15 | | Finally: Merck Ebola vax triumphs in phase III trial, overcoming logistical nightmare and more... |
| 2015-07-31 00:15 | | Amgen profit tops Street view, boosts full-year forecast and more... |
| 2015-07-30 12:15 | | Are Teva Earnings Enough? and more... |
| 2015-07-30 00:15 | | Ariad sells off a share of Iclusig for a shot at $200M in R&D cash and more... |
| 2015-07-29 12:15 | | The Secret to Vertex Pharmaceuticals' Success and more... |
| 2015-07-29 00:15 | | New drug approval is a win for the Bay State's horse in the hepatitis C race and more... |
| 2015-07-28 12:15 | | Wait, Will Allergan Really Buy Biogen or Amgen? and more... |
| 2015-07-28 00:15 | | Why Regeneron’s Approval is Bad News For Esperion Therapeutics and more... |
| 2015-07-27 12:15 | | Will marketing make the difference in approval of Sprout's 'pink pill' for women? and more... |
| 2015-07-27 00:15 | | 3 Biotech Stocks That Could Double Before 2016 and more... |
| 2015-07-26 12:15 | | Allergan To Buy Antidepressant Maker For $560 Million With Hopes Of Preventing Suicides and more... |
| 2015-07-25 12:15 | | Europe Biotechs Aim to Catch Americans as Investors Embrace IPOs and more... |
| 2015-07-25 00:15 | | World's first malaria vaccine gets go-ahead from EU regulators and more... |
| 2015-07-24 12:15 | | Abbott has lots of dry powder for medtech M&A and more... |
| 2015-07-24 00:15 | | Novartis whacks 3 Sandoz plants, 770 jobs, despite generic units' sales growth and more... |
| 2015-07-23 12:15 | | Lilly sales inch up on demand for animal health, new drugs and more... |
| 2015-07-23 00:15 | | Anthem Nearing Deal to Buy Cigna for $48 Billion and more... |
| 2015-07-22 12:15 | | Will The High Cost Of Vertex's New Cystic Fibrosis Drug Push The U.S. To European Style Pricing? and more... |
| 2015-07-22 00:15 | | Big Week for Biogen and more... |
| 2015-07-21 12:15 | | Biotech Investing Hits An All-Time High--But Is It a Bubble? and more... |
| 2015-07-21 00:15 | | Why Genzyme isn't worried about a threat by Amicus to its next Fabry drug and more... |
| 2015-07-20 12:15 | | FDA grants AbbVie's anti-tau drug orphan status and more... |
| 2015-07-20 00:15 | | AstraZeneca Has An Oncology Pipeline Packed With Potential and more... |
| 2015-07-18 12:15 | | 6 Big-Cap Drugmakers Reporting Earnings Next Week and more... |
| 2015-07-18 00:15 | | Pharma needs to get into digital health data game to stay competitive, study says and more... |
| 2015-07-17 12:15 | | Up with Endo, Down with Allergan…Sort Of and more... |
| 2015-07-17 00:15 | | Novo Nordisk says Flexpro PenMate gets FDA approval and more... |
| 2015-07-16 12:15 | | Broader Statin Use Shown To Be Cost Effective And Save Lives. Will This Convince 'Pharma-Skeptics?' and more... |
| 2015-07-16 00:15 | | Celgene's $7.2B buyout gets a big thumbs up, but is the deal really done? and more... |
| 2015-07-15 12:15 | | J&J chief touts $1B-plus prospects for coming psoriasis med guselkumab and more... |
| 2015-07-15 00:15 | | Why next week's Alzheimer’s drug trial results from Biogen will be closely watched and more... |
| 2015-07-14 12:15 | | Amgen awaiting FDA decision on cancer drug Kyprolis and more... |
| 2015-07-14 00:15 | | Shire Deepens Push Into Biotech After AbbVie Drops Bid and more... |
| 2015-07-13 12:15 | | Neos angles for a $74M IPO to fund its ADHD drugs and more... |
| 2015-07-12 12:15 | | U.S. proposes bundling some Medicare knee, hip replacement payments and more... |
| 2015-07-11 12:15 | | FDA support for Lilly cancer drug comes down to unmet needs vs side effects and more... |
| 2015-07-11 00:15 | | FDA approves Otsuka and Lundbeck's schizophrenia treatment and more... |
| 2015-07-10 12:15 | | Horizon's Hostile Bid for DepoMed Is Too Low and more... |
| 2015-07-10 00:15 | | Study links Prozac, Paxil use with birth defects and more... |
| 2015-07-09 12:15 | | The FDA Breathes New Life Into Esperion's ETC-1002 and more... |
| 2015-07-08 12:15 | | Roche's MS hopeful will amp up payer pricing pressure, analyst says and more... |
| 2015-07-08 00:15 | | Pfizer's Viagra first ED drug available in single-dose packets and more... |
| 2015-07-07 12:15 | | Mylan didn't disclose director's ties to HQ land deal: WSJ and more... |
| 2015-07-07 00:15 | | Allergan to drop $125m on Oculeve and more... |
| 2015-07-06 12:15 | | Biogen Collaboration With Applied Genetic Is 'Interesting,' But Morgan Stanley Will Wait For More Data and more... |
| 2015-07-05 12:15 | | Exelixis to Investors: "Wait for It... No, Seriously, Wait for It!" and more... |
| 2015-07-04 00:15 | | Sarepta Therapeutics One Step Closer to Drug Approval and more... |
| 2015-07-03 12:15 | | 3 Experimental Cancer Drugs Investors Should Be Closely Watching and more... |
| 2015-07-03 00:15 | | Vertex Wins U.S. Approval for Cystic Fibrosis Combo Orkambi and more... |
| 2015-07-02 12:15 | | Drug price increases hit record for Q2, with no sign of slowdown, analysts say and more... |
| 2015-07-02 00:15 | | [video]Should The Biotech Bubble Be Feared? and more... |
| 2015-07-01 12:15 | | How The Feds Discourage Prescription Drug Competition and more... |
| 2015-07-01 00:15 | | Pharma giant GlaxoSmithKline reveals $175K paid to hundreds of Triangle doctors and more... |
